ArticleCureus2025
Association Between Depression and Medication Adherence Among Post-myocardial Infarction Patients in a South Asian Clinical Setting.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMedication adherence is vital for successful recovery after a myocardial infarction (MI). Unfortunately, many patients experience depression following an MI, which can negatively affect their ability to stick to prescribed medication plans. It is important to explore how depression influences medication adherence, especially in South Asian clinical environments where cultural factors can significantly impact health outcomes.
methodsA cross-sectional study was carried out among 385 post-MI patients who attended outpatient clinics in Islamabad, Pakistan. The Patient Health Questionnaire-9 (PHQ-9) was used to measure depression, and the Morisky Medication Adherence Scale (MMAS-8) was used to quantify medication adherence. Statistical tests involved descriptive statistics, normality tests using Shapiro-Wilk, Spearman correlation, Kruskal-Wallis, chi-square, and linear regression. Data were collected between January and May 2025.
resultsThere was also a weak, statistically significant positive relation between the PHQ-9 and the MMAS-8 scores (r = 0.124, p < 0.05). In a linear regression model, PHQ-9 scores were significantly predictive of MMAS-8 scores (B = 0.064, p = 0.002), which means that the higher the depressive symptoms, the more likely medication adherence was. Depression scores worsened over time since MI and heavier medication burden, whereas adherence was highest among patients taking moderate numbers of medications (three to five/day). The rates of adherence and psychological distress also differed significantly depending on the treatment type, with the best rates being in angioplasty patients.
conclusionThis study, unlike the majority of the previous findings, reported a minor positive correlation between self-reported medication adherence and depressive symptoms in post-MI patients. The findings indicate that, in particular, in the cultural backdrop, depressive symptoms can be present alongside more health conscientiousness or planned-out care use. Comorbidities and complexities of treatment should be assessed, and mental health screening and adherence support to medications should be a component of post-MI care strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.